The export of local companies feeds into a perpetual cycle -- the export of Ontario IP and the accompanying need to import healthcare end products. [...] This investment is the largest state cancer research investment in the history of the US and has resulted in Texas now boasting a booming hub of life sciences companies. [...] What policies could stem and then potentially turn around the flood of IP, companies and trained graduates flowing south of the border? How can Ontario compete with Quebec incentives or replicate the local tech industry boom in the life sciences sector, developing sustainable receptors to retain the local talent trained at our publicly-funded universities? To secure jobs and prosperity in a compet. [...] To maximize the impact of Ontario’s inadequate seed capital supply, while also addressing current gaps and opportunities in the market, funds should first be focused on an immediate, underdeveloped opportunity and one that carries the greatest impact for the location of companies and jobs: seed-stage investing. [...] on360.ca | ontario.360@utoronto.ca Page 5 Conclusion Ontario is at a crossroads: the economic consequences of the pandemic and other pressures have put the sustainability of Ontario’s momentum in life sciences innovation and its growing leadership position at risk.
- Pages
- 6
- Published in
- Canada
